Transactions 17
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
|
2026-09-21 16:24 |
2026-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
M - OptEx |
$0.00 |
+6,250 |
385.1K |
+2% |
$0 |
|
2026-09-21 16:24 |
2026-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$3.39 |
-2,775 |
382.3K |
-0.7% |
-$9,407 |
| M |
2026-02-18 |
2026-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$1.89 |
-17.2K |
400.5K |
-4% |
-$32.6K |
| M |
2026-02-18 |
2026-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
M - OptEx |
$0.00 |
+34.7K |
402.3K |
+9% |
$0 |
|
2026-02-18 |
2026-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
A - Grant |
$0.00 |
+240.0K |
402.3K |
+148% |
$0 |
|
2025-09-19 |
2025-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
M - OptEx |
$0.00 |
+6,250 |
165.1K |
+4% |
$0 |
|
2025-09-19 |
2025-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$3.32 |
-2,775 |
162.3K |
-2% |
-$9,213 |
| DM |
2025-02-18 |
2025-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$3.19 |
-6,422 |
165.1K |
-4% |
-$20.5K |
| D |
2025-02-18 |
2025-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
A - Grant |
$0.00 |
+87.1K |
169.7K |
+105% |
$0 |
| D |
2024-11-12 |
2024-11-07 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
M - OptEx |
— |
+3,750 |
85.5K |
+5% |
— |
| D |
2024-11-12 |
2024-11-07 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$6.04 |
-1,102 |
84.4K |
-1% |
-$6,656 |
|
2024-09-20 |
2024-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$6.38 |
-1,837 |
81.8K |
-2% |
-$11.7K |
| D |
2024-09-17 |
2024-09-16 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$6.36 |
-661 |
83.6K |
-0.8% |
-$4,204 |
| D |
2024-09-17 |
2024-09-16 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
M - OptEx |
— |
+2,250 |
84.3K |
+3% |
— |
| D |
2024-02-15 |
2024-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
A - Grant |
$0.00 |
+36.7K |
82.0K |
+81% |
$0 |
| D |
2024-02-15 |
2024-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
F - Tax |
$6.53 |
-1,301 |
45.3K |
-3% |
-$8,496 |
| D |
2023-09-19 |
2023-09-18 |
CCCC |
C4 Therapeutics, Inc. |
Adams Kendra |
CFO |
A - Grant |
$0.00 |
+25.0K |
46.6K |
+116% |
$0 |
Purchase
Sale
Sale after option exercise
All abbreviations